Cargando…
Systemic Treatments for Mesothelioma: Standard and Novel
Systemic therapy is the only treatment option for the majority of mesothelioma patients, for whom age, co-morbid medical illnesses, non-epithelial histology, and locally advanced disease often preclude surgery. For many years, chemotherapy had a minimal impact on the natural history of this cancer,...
Autor principal: | Kindler, Hedy Lee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782121/ https://www.ncbi.nlm.nih.gov/pubmed/18770046 http://dx.doi.org/10.1007/s11864-008-0071-3 |
Ejemplares similares
-
A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic
por: Church, Matt, et al.
Publicado: (2021) -
Moral distress in mesothelioma and lung cancer nurses during the COVID-19 pandemic: insights from a UK survey
por: Hargreaves, Sarah, et al.
Publicado: (2023) -
Successful treatment of a patient with oligometastatic mesothelioma to the brain
por: Li, Selena S., et al.
Publicado: (2020) -
Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015) -
Catching a shark while looking for flounders
por: Orlandi, Riccardo, et al.
Publicado: (2023)